
Tianjin Medical Journal ›› 2023, Vol. 51 ›› Issue (3): 315-319.doi: 10.11958/20221201
• Applied Research • Previous Articles Next Articles
WANG Sisi(
), XIE Shuangshuang, MENG Yuexiu, ZHANG Xiangyun, LIU Yunchun
Received:2022-08-01
Revised:2022-10-11
Published:2023-03-15
Online:2023-03-02
WANG Sisi, XIE Shuangshuang, MENG Yuexiu, ZHANG Xiangyun, LIU Yunchun. The diagnostic value of TIM-3 and GATA-3 levels in maternal blood and amniotic fluid for premature rupture of membranes complicated with intrauterine infection[J]. Tianjin Medical Journal, 2023, 51(3): 315-319.
CLC Number:
| 基因名称 | 引物序列(5′→3′) | 产物大小(bp) |
|---|---|---|
| TIM-3 | 上游:ACCTGAAGTTGGTCATCAAACCA | 227 |
| 下游:CCTTGGAAAGGCTGCAGTGA | ||
| GATA-3 | 上游:AGGGAGTGTGTGAACTGTGGG | 284 |
| 下游:CTTCGCTTGGGCTTAATGAGG | ||
| GAPDH | 上游:GAGTCAACGGATTTGGTCGTT | 213 |
| 下游:TTGATTTTGGAGGGATCTCG |
Tab.1 Primer sequence
| 基因名称 | 引物序列(5′→3′) | 产物大小(bp) |
|---|---|---|
| TIM-3 | 上游:ACCTGAAGTTGGTCATCAAACCA | 227 |
| 下游:CCTTGGAAAGGCTGCAGTGA | ||
| GATA-3 | 上游:AGGGAGTGTGTGAACTGTGGG | 284 |
| 下游:CTTCGCTTGGGCTTAATGAGG | ||
| GAPDH | 上游:GAGTCAACGGATTTGGTCGTT | 213 |
| 下游:TTGATTTTGGAGGGATCTCG |
| 组别 | n | 血浆 | 羊水 | ||
|---|---|---|---|---|---|
| TIM-3 | GATA-3 | TIM-3 | GATA-3 | ||
| 对照组 | 45 | 1.03±0.14 | 1.05±0.13 | 1.01±0.10 | 0.99±0.12 |
| 未感染组 | 47 | 1.42±0.25a | 0.83±0.15a | 1.47±0.22a | 0.78±0.14a |
| 感染组 | 42 | 1.83±0.31ab | 0.62±0.12ab | 1.86±0.29ab | 0.59±0.13ab |
| F | 118.620** | 111.190** | 168.942** | 102.437** | |
Tab.2 Comparison of TIM-3 and GATA-3 mRNA levels in whole blood and amniotic fluid between the control group, the uninfected group and the infection group
| 组别 | n | 血浆 | 羊水 | ||
|---|---|---|---|---|---|
| TIM-3 | GATA-3 | TIM-3 | GATA-3 | ||
| 对照组 | 45 | 1.03±0.14 | 1.05±0.13 | 1.01±0.10 | 0.99±0.12 |
| 未感染组 | 47 | 1.42±0.25a | 0.83±0.15a | 1.47±0.22a | 0.78±0.14a |
| 感染组 | 42 | 1.83±0.31ab | 0.62±0.12ab | 1.86±0.29ab | 0.59±0.13ab |
| F | 118.620** | 111.190** | 168.942** | 102.437** | |
| 组别 | n | 血清 | |||
|---|---|---|---|---|---|
| TIM-3蛋白(ng/L) | GATA-3蛋白(μg/L) | ||||
| 对照组 | 45 | 214.39±33.76 | 362.49±37.25 | ||
| 未感染组 | 47 | 285.32±38.51a | 298.62±32.21a | ||
| 感染组 | 42 | 342.77±40.82ab | 258.46±29.04ab | ||
| F | 126.482** | 110.019** | |||
| 组别 | 羊水 | ||||
| TIM-3蛋白(ng/L) | GATA-3蛋白(μg/L) | ||||
| 对照组 | 227.83±35.12 | 346.72±36.09 | |||
| 未感染组 | 305.14±39.23a | 287.41±32.85a | |||
| 感染组 | 360.57±42.58ab | 239.53±27.68ab | |||
| F | 127.491** | 118.987** | |||
Tab.3 Comparison of TIM-3 and GATA-3 protein levels in serum and amniotic fluid between the control group, the uninfected group and the infection group
| 组别 | n | 血清 | |||
|---|---|---|---|---|---|
| TIM-3蛋白(ng/L) | GATA-3蛋白(μg/L) | ||||
| 对照组 | 45 | 214.39±33.76 | 362.49±37.25 | ||
| 未感染组 | 47 | 285.32±38.51a | 298.62±32.21a | ||
| 感染组 | 42 | 342.77±40.82ab | 258.46±29.04ab | ||
| F | 126.482** | 110.019** | |||
| 组别 | 羊水 | ||||
| TIM-3蛋白(ng/L) | GATA-3蛋白(μg/L) | ||||
| 对照组 | 227.83±35.12 | 346.72±36.09 | |||
| 未感染组 | 305.14±39.23a | 287.41±32.85a | |||
| 感染组 | 360.57±42.58ab | 239.53±27.68ab | |||
| F | 127.491** | 118.987** | |||
| 组别 | n | 血浆 | 羊水 | ||
|---|---|---|---|---|---|
| TIM-3 | GATA-3 | TIM-3 | GATA-3 | ||
| 轻度组 | 16 | 1.62±0.28 | 0.75±0.14 | 1.63±0.25 | 0.72±0.15 |
| 中度组 | 17 | 1.87±0.32a | 0.60±0.12a | 1.90±0.30a | 0.58±0.12a |
| 重度组 | 9 | 2.14±0.35ab | 0.45±0.09ab | 2.23±0.32ab | 0.40±0.11ab |
| F | 8.209** | 17.748** | 12.829** | 17.486** | |
Tab.4 Comparison of TIM-3 and GATA-3 mRNA levels in whole blood and amniotic fluid between pregnant women with different infection degrees
| 组别 | n | 血浆 | 羊水 | ||
|---|---|---|---|---|---|
| TIM-3 | GATA-3 | TIM-3 | GATA-3 | ||
| 轻度组 | 16 | 1.62±0.28 | 0.75±0.14 | 1.63±0.25 | 0.72±0.15 |
| 中度组 | 17 | 1.87±0.32a | 0.60±0.12a | 1.90±0.30a | 0.58±0.12a |
| 重度组 | 9 | 2.14±0.35ab | 0.45±0.09ab | 2.23±0.32ab | 0.40±0.11ab |
| F | 8.209** | 17.748** | 12.829** | 17.486** | |
| 组别 | n | 血清 | |||
|---|---|---|---|---|---|
| TIM-3蛋白(ng/L) | GATA-3蛋白(μg/L) | ||||
| 轻度组 | 16 | 297.40±39.27 | 288.31±30.42 | ||
| 中度组 | 17 | 351.65±41.38a | 254.01±29.16a | ||
| 重度组 | 9 | 406.71±43.25ab | 204.47±26.49ab | ||
| F | 21.319** | 23.921** | |||
| 组别 | 羊水 | ||||
| TIM-3蛋白(ng/L) | GATA-3蛋白(μg/L) | ||||
| 轻度组 | 317.49±40.17 | 273.13±29.72 | |||
| 中度组 | 366.82±43.64a | 234.54±27.05a | |||
| 重度组 | 425.27±44.85ab | 189.24±25.23ab | |||
| F | 18.746** | 26.768** | |||
表5 Comparison of TIM-3 and GATA-3 protein levels in serum and amniotic fluid between pregnant women with different infection degrees
| 组别 | n | 血清 | |||
|---|---|---|---|---|---|
| TIM-3蛋白(ng/L) | GATA-3蛋白(μg/L) | ||||
| 轻度组 | 16 | 297.40±39.27 | 288.31±30.42 | ||
| 中度组 | 17 | 351.65±41.38a | 254.01±29.16a | ||
| 重度组 | 9 | 406.71±43.25ab | 204.47±26.49ab | ||
| F | 21.319** | 23.921** | |||
| 组别 | 羊水 | ||||
| TIM-3蛋白(ng/L) | GATA-3蛋白(μg/L) | ||||
| 轻度组 | 317.49±40.17 | 273.13±29.72 | |||
| 中度组 | 366.82±43.64a | 234.54±27.05a | |||
| 重度组 | 425.27±44.85ab | 189.24±25.23ab | |||
| F | 18.746** | 26.768** | |||
| 指标 | AUC(95%CI) | 敏感 度(%) | 特异 度(%) | 截断值 |
|---|---|---|---|---|
| 血清TIM-3蛋白 | 0.854(0.777~0.931) | 81.0 | 78.7 | 309.74 ng/L |
| 血清GATA-3蛋白 | 0.813(0.721~0.904) | 78.6 | 85.1 | 279.46 μg/L |
| 血清TIM-3联合 GATA-3蛋白 | 0.937(0.886~0.988) | 90.5 | 83.0 | - |
| 羊水TIM-3蛋白 | 0.834(0.749~0.919) | 83.3 | 78.7 | 328.33 ng/L |
| 羊水GATA-3蛋白 | 0.850(0.771~0.929) | 78.6 | 78.7 | 252.63 μg/L |
| 羊水TIM-3联合 GATA-3蛋白 | 0.922(0.869~0.976) | 92.9 | 76.6 | - |
Tab.6 Efficacy of TIM-3 and GATA-3 proteins in serum and amniotic fluid alone and in combination in diagnosing intrauterine infection in pregnant women with PROM
| 指标 | AUC(95%CI) | 敏感 度(%) | 特异 度(%) | 截断值 |
|---|---|---|---|---|
| 血清TIM-3蛋白 | 0.854(0.777~0.931) | 81.0 | 78.7 | 309.74 ng/L |
| 血清GATA-3蛋白 | 0.813(0.721~0.904) | 78.6 | 85.1 | 279.46 μg/L |
| 血清TIM-3联合 GATA-3蛋白 | 0.937(0.886~0.988) | 90.5 | 83.0 | - |
| 羊水TIM-3蛋白 | 0.834(0.749~0.919) | 83.3 | 78.7 | 328.33 ng/L |
| 羊水GATA-3蛋白 | 0.850(0.771~0.929) | 78.6 | 78.7 | 252.63 μg/L |
| 羊水TIM-3联合 GATA-3蛋白 | 0.922(0.869~0.976) | 92.9 | 76.6 | - |
| [1] | DARLING A J, HARRIS H M, ZEMTSOV G E, et al. Risk factors for adverse maternal outcomes following expectantly managed preterm prelabor rupture of membranes[J]. Am J Perinatol, 2022, 39(8):803-807. doi:10.1055/s-0041-1740011. |
| [2] | ZHU J, MA C, ZHU L, et al. A role for the NLRC4 inflammasome in premature rupture of membrane[J]. PLoS One, 2020, 15(8):e0237847. doi:10.1371/journal.pone.0237847. |
| [3] | FAROOQUI R, SIDDIQUI Q U. Diagnostic accuracy of procalcitonin in maternal plasma to detect early intra-amniotic infection in preterm premature rupture of the membranes with respect of highvaginal swab as gold standard[J]. Pak J Med Sci, 2022, 38(1):310-314. doi:10.12669/pjms.38.1.4436. |
| [4] | BEN M'BAREK I, LANDRAUD L, DESFRERE L, et al. Contribution of vaginal culture to predict early onset neonatal infection in preterm prelabor rupture of membranes[J]. Eur J Obstet Gynecol Reprod Biol, 2021, 261:78-84. doi:10.1016/j.ejogrb.2021.04.016. |
| [5] | 狄红丽, 郝树磊, 杨彩凤, 等. β-HCG、CRP和TNF-α联合检测在胎膜早破宫内感染中的预测作用[J]. 分子诊断与治疗杂志, 2022, 14(3):483-486. |
| DI H L, HAO S L, YANG C F, et al. Predictive role of combined detection of β-HCG,CRP and TNF-α in intrauterine infection in premature rupture of membranes[J]. Journal of Molecular Diagnostics and Therapy, 2022, 14(3):483-486. doi:10.3969/j.issn.1674-6929.2022.03.031. | |
| [6] | YANG R, SUN L, LI C F, et al. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy[J]. Nat Commun, 2021, 12(1):832. doi:10.1038/s41467-021-21099-2. |
| [7] | 陈国华, 黄为民, 潘志伟, 等. 反复喘息婴幼儿外周血单核细胞中T-bet/GATA-3比值与潮气呼吸肺功能及Th1/Th2细胞平衡的关系[J]. 中国医药导报, 2021, 18(3):26-29,34. |
| CHEN G H, HUANG W M, PAN Z W, et al. Relationship between T-bet/GATA-3 ratio in peripheral blood mononu-clear cells and tidal breathes lung function and Th1/Th2 cell balance in recurrent wheezing infants[J]. Chin Med Herald, 2021, 18(3):26-29,34. | |
| [8] | 谢幸, 苟文丽. 妇产科学[M]. 8版. 北京: 人民卫生出版社, 2013:138-139. |
| XIE X, GOU W L. Obstetrics and gynecology[M]. 8th ed. Beijing: People's Health Publishing House, 2013:138-139. | |
| [9] | 孙晓霞, 张兆波, 张玉枝, 等. 血清β-HCG,hsCRP及CRP检测对胎膜早破宫内感染的诊断价值[J]. 现代生物医学进展, 2016, 16(22):4363-4366. |
| SUN X X, ZHANG Z B, ZHANG Y Z, et al. Predictive value of serum β-HCG,hsCRP and CRP levels on intrauterine infection of pregnant women with premature rupture of membranes[J]. Progress in Modern Biomedicine, 2016, 16(22):4363-4366. doi:10.13241/j.cnki.pmb.2016.22.043. | |
| [10] | LI L, YAN Y, QI H, et al. A risk score for the early prediction of postpartum bloodstream infections in patients with premature rupture of membranes:A pilot study[J]. Int J Gynaecol Obstet, 2020, 150(3):419-420. doi:10.1002/ijgo.13169. |
| [11] | OH K J, ROMERO R, PARK J Y, et al. The earlier the gestational age,the greater the intensity of the intra-amniotic inflammatory response in women with preterm premature rupture of membranes and amniotic fluid infection by Ureaplasma species[J]. J Perinat Med, 2019, 47(5):516-527. doi:10.1515/jpm-2019-0003. |
| [12] | BONASONI M P, PALICELLI A, DALLA DEA G, et al. Klebsiella pneumoniae chorioamnionitis:An underrecognized cause of preterm premature rupture of membranes in the second trimester[J]. Microorganisms, 2021, 9(1):96. doi:10.3390/microorganisms9010096. |
| [13] | RONZONI S, STECKLE V, D'SOUZA R, et al. Cytokine changes in maternal peripheral blood correlate with time-to-delivery in pregnancies complicated by premature prelabor rupture of the membranes[J]. Reprod Sci, 2019, 26(9):1266-1276. doi:10.1177/1933719118815590. |
| [14] | ZILBER E, MARTIN G E, WILLBERG C B, et al. Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection[J]. AIDS, 2019, 33(7):1253-1256. doi:10.1097/QAD.0000000 000002165. |
| [15] | 刘叶, 王缚鲲, 汤菲. TIM-3抑制对支气管哮喘患者免疫平衡功能的影响[J]. 解放军医药杂志, 2019, 31(10):43-46. |
| LIU Y, WANG F K, TANG F. Effect of TIM-3 inhibition on immune balance function in patients with bronchial asthma[J]. Medical & Pharmaceutical Journal of Chinese People's Liberation Army, 2019, 31(10):43-46. doi:10.3969/j.issn.2095-140X.2019.10.010. | |
| [16] | 李雪莲, 丁华, 姜忠训, 等. Tim-3在早期自然流产中的作用及与Th17/Treg细胞的关系[J]. 广州医科大学学报, 2019, 47(1):6-9. |
| LI X L, DING H, JIANG Z X, et al. The role of Tim-3 in early spontaneous abortion and its relationship with Th17/Treg cells[J]. Academic Journal of Guangzhou Medical University, 2019, 47(1):6-9. doi:10.3969/j.issn.2095-9664.2019.01.02. | |
| [17] | 卿吉琳, 陈治中, 谭卫红. TIM-3-Gal-9信号途径在原因不明复发性流产中的研究进展[J]. 中国免疫学杂志, 2018, 34(11):1743-1747. |
| QING J L, CHEN Z Z, TAN W H. Research progress of TIM-3-Gal-9 pathway in unexplained recurrent spontaneous abortion[J]. Chinese Journal of Immunology, 2018, 34(11):1743-1747. doi:10.3969/j.issn.1000-484X.2018.11.031. | |
| [18] | XIAO L, MA L, WANG Z, et al. Deciphering a distinct regulatory network of TEAD4, CDX2 and GATA3 in humans for trophoblast transition from embryonic stem cells[J]. Biochim Biophys Acta Mol Cell Res, 2020, 1867(9): 118736. doi:10.1016/j.bbamcr.2020.118736. |
| [19] | HERTWECK A, VILA DE MUCHA M, BARBER P R, et al.The TH1 cell lineage-determining transcription factor T-bet suppresses TH2 gene expression by redistributing GATA3 away from TH2 genes[J]. Nucleic Acids Res, 2022, 50(8):4557-4573. doi:10.1093/nar/gkac258. |
| [20] | 褚娜利, 聂风华, 刘玉欣, 等. Torch感染与自然流产及Th1/Th2细胞因子水平相关分析[J]. 中国实验诊断学, 2021, 25(9):1368-1369. |
| CHU N L, NIE F H, LIU Y X, et al. Correlation analysis of Torch infection with spontaneous abortion and Th1/Th2 cytokine level[J]. Chinese Journal of Laboratory Diagnosis, 2021, 25(9):1368-1369. doi:10.3969/j.issn.1007-4287.2021.09.034. |
| [1] | ZHENG Shaoyang, ZHI Hui, WANG Man, WU Bing, ZHANG Qingge, LI Guanyang. Correlation between levels of sTim-3 and sST2 in peripheral blood and disease severity in patients with alcoholic liver disease [J]. Tianjin Medical Journal, 2025, 53(4): 383-388. |
| [2] | ZHAO Caiyun, HUA Shaofang. Clinical analysis and prediction of intrauterine fetal death in late trimester of pregnancy [J]. Tianjin Medical Journal, 2023, 51(4): 436-440. |
| [3] | . Relationship between TLR3 expression in placenta and intrauterine infection of hepatitis B virus [J]. , 2010, 38(12): 1028-1031 . |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||